Inflammatory Bowel Diseases: New Insights Into Mechanisms of Inflammation and Challenges in Diagnosis and TreatmentE. Monteiro, F. Tavarelo Veloso This volume contains the proceedings of Falk Symposium No. 76, held in Estoril, Portugal, May 5--7, 1994, and presents a modern aetiopathogenesis-based approach to clinical, diagnostic and therapeutic developments in inflammatory bowel disease. The first section deals with the first results of a prospective epidemiological study in the EEC countries, while subsequent sections cover the most important factors responsible for IBD, diagnosis, controversies in clinical management, new insights into therapy, and difficult clinical problems. The book closes with a state-of-the-art overview of the new knowledge as well as future perspectives regarding diagnosis and treatment. It will be of interest to all clinicians and researchers in this important area of gastroenterology. |
From inside the book
Results 1-3 of 79
Page 42
... treating colitis rats with anti - CR3 monoclonal antibodies raised in mice . In rats , CR3 is recognized by several monoclonal antibodies i.e. ED7 , ED8 and Ox4214,15 . After intra- venous treatment with anti - CR3 antibodies in TNBS ...
... treating colitis rats with anti - CR3 monoclonal antibodies raised in mice . In rats , CR3 is recognized by several monoclonal antibodies i.e. ED7 , ED8 and Ox4214,15 . After intra- venous treatment with anti - CR3 antibodies in TNBS ...
Page 176
... treatment After treatment Basal CRF Basal CRF Fig . 1 Cortisol concentrations with and without CRF stimulation before and after 6 weeks budesonide treatment ( 3 × 3 mg ) in active Crohn's disease Table 2 Ongoing studies with budesonide ...
... treatment After treatment Basal CRF Basal CRF Fig . 1 Cortisol concentrations with and without CRF stimulation before and after 6 weeks budesonide treatment ( 3 × 3 mg ) in active Crohn's disease Table 2 Ongoing studies with budesonide ...
Page 332
... treatment of patients with ulcerative colitis . However , our experimental data suggest that this treatment will not have strong effects on the control of severe ulcerative colitis . Table 1 Comparison of lipid peroxidation products ...
... treatment of patients with ulcerative colitis . However , our experimental data suggest that this treatment will not have strong effects on the control of severe ulcerative colitis . Table 1 Comparison of lipid peroxidation products ...
Contents
IBD in the north of Portugal | 3 |
Almada Seixal Sesimbra | 9 |
Epidemiology of IBD in Vigo health area Spain | 17 |
Copyright | |
27 other sections not shown
Other editions - View all
Common terms and phrases
abdominal acid active Crohn's disease acute antibiotics antibodies antigens arthritis associated bacteria biopsies budesonide CDAI chronic Clin clinical colectomy colitis and Crohn's colonic mucosa colonoscopy colorectal cancer Crohn's disease cyclosporin cytokines detected diagnosis diet disease activity distal dose drug dysplasia effect endoscopic enema Epidemiology epithelial cells experimental colitis extraintestinal factors faecal Falk Symposium fistulas Gastroenterology gene genetic granulocytes histological IBD patients ileal ileum immune Immunol immunosuppressive increased indeterminate colitis induced inflammation inflammatory bowel disease interleukin intestinal inflammation intravenous lesions leucocyte macrophages mediators mesalazine metabolism methotrexate molecules mucosal neutrophils nitric oxide nutrition oral paratuberculosis pathogenesis patients with Crohn's patients with IBD patients with ulcerative peroxynitrite population pouchitis present proctitis protein rats receptor rectal rectum relapse remission risk role Scand J Gastroenterol side-effects steroids sulphide surgery surgical surveillance symptoms Table therapeutic therapy tissue toxic megacolon treatment ulcerative colitis